scholarly journals Ultrasound features of a metastatic seminal vesicle melanoma: A case report

2016 ◽  
Vol 88 (4) ◽  
pp. 347 ◽  
Author(s):  
Andrea Fabiani ◽  
Emanuele Principi ◽  
Alessandra Filosa ◽  
Fabrizio Fioretti ◽  
Valentina Maurelli ◽  
...  
Keyword(s):  
Seminal Vesicle ◽  
Ultrasound Examination ◽  
Transrectal Ultrasound ◽  
Digital Rectal Examination ◽  
Primary Melanoma ◽  
Unknown Primary ◽  
Ultrasound Guided ◽  
Rectal Examination ◽  
The Right ◽  
Ultrasound Features

In this report we describe what we consider to be the second case of seminal vescicle (SV) metastasis from an unknown primary melanoma. only presenting symptom was a palpable firm nodule of the right prostate base on digital rectal examination (DRE). The diagnosis, after prostatic transrectal ultrasound examination (TRUS), was performed by ultrasound guided biopsy. We underline that prostatic TRUS evaluation is mandatory in case of abnormal digital rectal examination. Seminal vesicle must be always evaluated.

scholarly journals Significance of Core Length in Current Transrectal Ultrasound-guided Prostate Biopsy in Patients with Normal Digital Rectal Examination

2020 ◽  
Vol 7 (2) ◽  
pp. 83-87
Author(s):  
Mesut Altan ◽  
Burak Çıtamak ◽  
Emin Mammadov ◽  
Naime Meriç Konar ◽  
Bülent Akdoğan ◽  
...  
Keyword(s):  
Prostate Biopsy ◽  
Transrectal Ultrasound ◽  
Digital Rectal Examination ◽  
Ultrasound Guided ◽  
Rectal Examination ◽  
Core Length

Case 12.13

2014 ◽  
pp. 588-589
Author(s):  
Christine U. Lee ◽  
James F. Glockner
Keyword(s):  
Seminal Vesicle ◽  
Digital Rectal Examination ◽  
Palpable Mass ◽  
Rectal Examination ◽  
The Right ◽  
T2 Weighted Images

46-year-old asymptomatic man with a palpable mass above the prostate on digital rectal examination Sagittal (Figure 12.13.1) and axial (Figure 12.13.2) FSE T2-weighted images reveal a complex multicystic lesion involving the right side of the seminal vesicle. Axial T1-weighted FSE image (...

scholarly journals The Initial Experience of Trans-Rectal Ultrasound and Biopsy in Diagnosis of Carcinoma Prostate In Gezira Hospital For Renal Disease And Surgery (GHRDS)

2017 ◽  
Vol 12 (1) ◽  
pp. 25
Author(s):  
Walaa Eldin Ibraheem ◽  
Sami Mahjoub Taha ◽  
Mustafa Omran Mansour ◽  
Mohammed El Imam Mohamed Ahmed
Keyword(s):  
Prostate Cancer ◽  
Transrectal Ultrasound ◽  
Digital Rectal Examination ◽  
Ultra Sound ◽  
Ultrasound Guided ◽  
Rectal Examination ◽  
Rectal Ultrasound ◽  
Carcinoma Prostate ◽  
Sextant Biopsy ◽  
Cancer Prostate

<p><strong>Background</strong>: Prostate cancer prevalent cancer in males above sixty-five worldwide, this lead to the introduction of screening of the PSA and using of the transrectal ultrasound scanning, and sextant biopsy of the prostate.</p><p><strong>Objectives</strong>: To compare the accuracy of the Transrectal Ultrasound guided biopsy (TRUS/BX) in the diagnosis of prostate cancer in Gezira Hospital for Renal Diseases and Surgery (GHRDS), with specific considerations to the digital rectal examination (DRE) findings and prostate specific antigen (PSA) level.                      .</p><p><strong>Materials and Methods</strong>:  This is a prospective, descriptive small-scale hospital based study.  A total of 297 patients with clinically symptomatic enlarged prostate underwent transrectal ultrasound guided true cut needle biopsy of the prostate were studied in (GHRDS) in the period from June2006 to June2009.                    </p><p><strong>Results</strong>: The majority 188 (63.3%) of patients were between 50-70 years of age. Abnormal digital rectal examination (DRE) like obliteration of the median sulcus, and fixed mucosa revealed higher incidence of carcinoma prostate (CaP) with a significant value (p= 0.0000). PSA level showed significant relation (p= 0.0001) with the diagnosis of carcinoma prostate. Transrectal U/S findings well correlated to the histopathological results, where abnormal findings (like hypo-echoic lesions or calcifications and cysts) showed higher incidence of malignancy in 46 patients constitute 52.8% of the abnormal U/S findings.</p><p><strong>Conclusions and recommendations</strong>: PSA level is highly sensitive but less specific in detection of prostate cancer. Normal DRE doesn’t exclude prostate cancer, fixed mucosa and obliterated median sulcus has the highest predictors of cancer prostate in DRE. Presence of calcifications and cyst on trans-rectal ultrasound has the highest liability for cancer prostate in compare to the other ultrasonic findings.                 </p><p><strong>Key words: </strong>Prostate cancer, DRE, PSA level, TRUS/ BX (Transrectal ultra sound biopsy), sextant biopsy.</p>

scholarly journals Histology results of systematic prostate biopsies by in-bore magnetic resonance imaging vs. transrectal ultrasound

2020 ◽  
Vol 15 (5) ◽  
Author(s):  
Alon Lazarovich ◽  
Gil Raviv ◽  
Yael Laitman ◽  
Orith Portnoy ◽  
Orit Raz ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Prostate Biopsy ◽  
Specific Antigen ◽  
Transrectal Ultrasound ◽  
Digital Rectal Examination ◽  
Resonance Imaging ◽  
Rectal Examination ◽  
Number Of Patients ◽  
Clinically Significant

Introduction: We aimed to compare systematic biopsies (SBs) of in-bore magnetic resonance-guided prostate biopsy (MRGpB) with those performed under transrectal ultrasound (TRUS) guidance in the clinical setting. Methods: Data on all 161 consecutive patients undergoing prostate biopsy in our institution between November 2017 and July 2019 were retrospectively collected. The patients were referred to biopsy due to elevated prostate-specific antigen (PSA) and/or abnormal digital rectal examination and/or at least one Prostate Imaging Reporting and Data System (PI-RADS) lesion score of ≥3 on multiparametric magnetic resonance imaging (mpMRI). We included patients with PSA levels ≤20 ng/ml and those with 8–12 core biopsies. Histology results of SBs performed by in-bore MRGpB were compared to TRUS SBs. Chi-squared, Fischer’s exact, and multivariate Pearson regression tests were used for statistical analysis (SPSS, IBM Corporation). Results: In total, 128 patients were eligible for analysis. Their median age was 68 years (interquartile range [IQR] 61.5–72), mean prostate size 55±29 cc, and mean PSA and PSA density levels 7.6±3.5 ng/ml and 0.18±0.13 ng/ml/cc, respectively. Thirty-five patients (27.3%) had suspicious digital rectal examination findings. Both biopsy groups were similar for these parameters. Thirty-eight (62.3%) MRGpB patients had a previous biopsy vs. 5 (7.1%) TRUS-SB patients (p<0.0001). The number of patients diagnosed with clinically significant and non-significant disease was similar for both groups. High-risk disease was more prevalent in the TRUS-SB group (22.4% vs. 4.9%, p<0.01). Conclusions: Our data suggest that in-bore MRGpB is no better than TRUS for guiding SBs for the detection of clinically significant prostate cancer.

Sign in / Sign up

Export Citation Format

Share Document